MEDIA

EDUCATION

Medical School

  • Tufts University School of Medicine , 1999 , Boston , MA

Residency

  • Children's Memorial Hospital , 2002 , Chicago , IL

Fellowship

Pediatric Gastroenterology
  • Boston Children's Hospital , 2005 , Boston , MA

Fellowship

Hepatology
  • Boston Children's Hospital , 2006 , Boston , MA

PROFESSIONAL HISTORY

Dr. Elisofon serves as the Medical Director of the Liver Transplant Program.  His specialties include childhood liver and biliary tract disease in addition to liver transplantation. Dr. Elisofon is board certified in Pediatric Gastroenterology and Pediatric Transplant Hepatology.

Dr. Elisofon is an active participant in SPLIT (Studies of Pediatric Liver Transplantation), a multi-center registry for Pediatric Liver Transplant. He has been a past committee member of the UNOS Pediatric Transplant Committee. 

Locally, Dr. Elisofon serves on the Medical Advisory Committee for the American Liver Foundation, New England Division.

CERTIFICATIONS

  • American Board of Pediatrics, Pediatric Gastroenterology
  • American Board of Pediatrics, Pediatrics Transplant Hepatology

PUBLICATIONS

Publications powered by Harvard Catalyst Profiles

  1. Lee E, Ramos-Gonzalez G, Rodig N, Elisofon S, Vakili K, Kim HB. Bilateral native nephrectomy to reduce oxalate stores in children at the time of combined liver-kidney transplantation for primary hyperoxaluria type 1. Pediatr Nephrol. 2018 May; 33(5):881-887. View abstract
  2. Valentino PL, Jonas MM, Lee CK, Kim HB, Vakili K, Elisofon SA. Outcomes after discontinuation of routine use of transanastomotic biliary stents in pediatric liver transplantation at a single site. Pediatr Transplant. 2016 Aug; 20(5):647-51. View abstract
  3. Al-Herz W, Chu JI, van der Spek J, Raghupathy R, Massaad MJ, Keles S, Biggs CM, Cockerton L, Chou J, Dbaibo G, Elisofon SA, Hanna-Wakim R, Kim HB, Lehmann LE, McDonald DR, Notarangelo LD, Veys P, Chatila TA, Geha RS, Gaspar HB, Pai SY. Hematopoietic stem cell transplantation outcomes for 11 patients with dedicator of cytokinesis 8 deficiency. J Allergy Clin Immunol. 2016 Sep; 138(3):852-859.e3. View abstract
  4. Schoettler M, Elisofon SA, Kim HB, Blume ED, Rodig N, Boyer D, Neufeld EJ, Grace RF. Treatment and outcomes of immune cytopenias following solid organ transplant in children. Pediatr Blood Cancer. 2015 02; 62(2):214-218. View abstract
  5. Squires RH, Dhawan A, Alonso E, Narkewicz MR, Shneider BL, Rodriguez-Baez N, Olio DD, Karpen S, Bucuvalas J, Lobritto S, Rand E, Rosenthal P, Horslen S, Ng V, Subbarao G, Kerkar N, Rudnick D, Lopez MJ, Schwarz K, Romero R, Elisofon S, Doo E, Robuck PR, Lawlor S, Belle SH. Intravenous N-acetylcysteine in pediatric patients with nonacetaminophen acute liver failure: a placebo-controlled clinical trial. Hepatology. 2013 Apr; 57(4):1542-9. View abstract
  6. Elisofon SA, Emerick KM, Sinacore JM, Alonso EM. Health status of patients with Alagille syndrome. J Pediatr Gastroenterol Nutr. 2010 Dec; 51(6):759-65. View abstract
  7. Zenzen W, Perez-Atayde AR, Elisofon SA, Kim HB, Alomari AI. Hepatic failure in a rapidly involuting congenital hemangioma of the liver: failure of embolotherapy. Pediatr Radiol. 2009 Oct; 39(10):1118-23. View abstract
  8. Elisofon SA, Jonas MM. Hepatitis B and C in children: current treatment and future strategies. Clin Liver Dis. 2006 Feb; 10(1):133-48, vii. View abstract